| Product Code: ETC4759177 | Publication Date: Nov 2023 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 60 | No. of Figures: 30 | No. of Tables: 5 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Greece Vaccines Market Overview |
3.1 Greece Country Macro Economic Indicators |
3.2 Greece Vaccines Market Revenues & Volume, 2021 & 2031F |
3.3 Greece Vaccines Market - Industry Life Cycle |
3.4 Greece Vaccines Market - Porter's Five Forces |
3.5 Greece Vaccines Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.6 Greece Vaccines Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.7 Greece Vaccines Market Revenues & Volume Share, By Disease Indication, 2021 & 2031F |
3.8 Greece Vaccines Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.9 Greece Vaccines Market Revenues & Volume Share, By Patient Type, 2021 & 2031F |
4 Greece Vaccines Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing government focus on immunization programs |
4.2.2 Rising awareness about the importance of vaccination |
4.2.3 Growing prevalence of infectious diseases in Greece |
4.3 Market Restraints |
4.3.1 Vaccine hesitancy among a segment of the population |
4.3.2 Regulatory challenges in vaccine approval and distribution |
5 Greece Vaccines Market Trends |
6 Greece Vaccines Market Segmentations |
6.1 Greece Vaccines Market, By Technology |
6.1.1 Overview and Analysis |
6.1.2 Greece Vaccines Market Revenues & Volume, By Conjugate vaccines, 2021-2031F |
6.1.3 Greece Vaccines Market Revenues & Volume, By Inactivated and subunit vaccines, 2021-2031F |
6.1.4 Greece Vaccines Market Revenues & Volume, By Live attenuated vaccines, 2021-2031F |
6.1.5 Greece Vaccines Market Revenues & Volume, By Recombinant vaccines, 2021-2031F |
6.1.6 Greece Vaccines Market Revenues & Volume, By Toxoid vaccines, 2021-2031F |
6.2 Greece Vaccines Market, By Type |
6.2.1 Overview and Analysis |
6.2.2 Greece Vaccines Market Revenues & Volume, By Monovalent vaccines, 2021-2031F |
6.2.3 Greece Vaccines Market Revenues & Volume, By Multivalent vaccines, 2021-2031F |
6.3 Greece Vaccines Market, By Disease Indication |
6.3.1 Overview and Analysis |
6.3.2 Greece Vaccines Market Revenues & Volume, By Pneumococcal disease, 2021-2031F |
6.3.3 Greece Vaccines Market Revenues & Volume, By DTP, 2021-2031F |
6.3.4 Greece Vaccines Market Revenues & Volume, By Influenza, 2021-2031F |
6.3.5 Greece Vaccines Market Revenues & Volume, By HPV, 2021-2031F |
6.3.6 Greece Vaccines Market Revenues & Volume, By Meningococcal disease, 2021-2031F |
6.3.7 Greece Vaccines Market Revenues & Volume, By Polio, 2021-2031F |
6.3.8 Greece Vaccines Market Revenues & Volume, By Other disease indications, 2021-2031F |
6.3.9 Greece Vaccines Market Revenues & Volume, By Other disease indications, 2021-2031F |
6.4 Greece Vaccines Market, By Route of Administration |
6.4.1 Overview and Analysis |
6.4.2 Greece Vaccines Market Revenues & Volume, By Intramuscular and subcutaneous administration, 2021-2031F |
6.4.3 Greece Vaccines Market Revenues & Volume, By Oral administration, 2021-2031F |
6.4.4 Greece Vaccines Market Revenues & Volume, By Other routes of administration, 2021-2031F |
6.5 Greece Vaccines Market, By Patient Type |
6.5.1 Overview and Analysis |
6.5.2 Greece Vaccines Market Revenues & Volume, By Pediatric patients, 2021-2031F |
6.5.3 Greece Vaccines Market Revenues & Volume, By Adult patients, 2021-2031F |
7 Greece Vaccines Market Import-Export Trade Statistics |
7.1 Greece Vaccines Market Export to Major Countries |
7.2 Greece Vaccines Market Imports from Major Countries |
8 Greece Vaccines Market Key Performance Indicators |
8.1 Vaccination coverage rates in key target groups |
8.2 Number of new vaccines introduced in the market |
8.3 Investment in research and development for new vaccines |
8.4 Public health expenditure on vaccination programs |
8.5 Percentage of healthcare professionals trained in vaccination protocols |
9 Greece Vaccines Market - Opportunity Assessment |
9.1 Greece Vaccines Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.2 Greece Vaccines Market Opportunity Assessment, By Type, 2021 & 2031F |
9.3 Greece Vaccines Market Opportunity Assessment, By Disease Indication, 2021 & 2031F |
9.4 Greece Vaccines Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.5 Greece Vaccines Market Opportunity Assessment, By Patient Type, 2021 & 2031F |
10 Greece Vaccines Market - Competitive Landscape |
10.1 Greece Vaccines Market Revenue Share, By Companies, 2024 |
10.2 Greece Vaccines Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations | 13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here